Skip to content

A single-center retrospective study of prognosis after hepatectomy for primary hepatocellular carcinoma

A single-center retrospective study of prognosis after hepatectomy for primary hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077493
Enrollment
Unknown
Registered
2023-11-10
Start date
2023-11-11
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary hepatic carcinoma

Interventions

Hepatectomy in newly treated HCC patients:None

Sponsors

The First Affiliated Hospital of PLA Army Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age =18 years old (2) Newly treated patients with primary liver cancer clinically diagnosed or hepatocellular liver cancer pathologically diagnosed (3) Primary liver cancer treated with hepatectomy (4) Primary liver cancer treated with chemotherapy within 30 days before hepatectomy (5) Primary liver cancer treated with Chinese patent medicine antitumor therapy within 30 days before hepatocellular carcinoma resection (6) Outpatient/inpatient visit record time or telephone follow-up time =1 year (7) Complete clinical data

Exclusion criteria

Exclusion criteria: (1) Liver transplantation was performed in patients with primary liver cancer (2) ALPPS surgery was performed in patients with primary liver cancer (3) PVE two-step hepatectomy was performed in patients with primary liver cancer (4) Hepatectomy combined with intraoperative radiofrequency ablation or combined perioperative radiofrequency ablation were performed in patients with primary liver cancer (5) TACE, radiotherapy and other anti-tumor treatments were performed for patients with primary liver cancer (6) Targeted drugs and immunotherapy were used for primary liver cancer patients (7) Patients undergoing liver transplantation after hepatectomy or radiofrequency ablation (8) Liver resection was performed for other types of tumors, such as cholangiocarcinoma, metastatic liver cancer, and adenocarcinoma (9) Liver resection was performed for benign diseases such as hemangioma, FNH and atypical hyperplasia (10) Hepatectomy was performed for hepatolithiasis (11) History of liver cancer treatment prior to surgery except for chemotherapy within 30 days (12) Partial liver resection combined with primary malignant tumor resection in other organs, such as hepatopancreatic duodenectomy, pancreaticocaudectomy combined with partial liver resection and nephrectomy. (13) Combined with primary malignant tumors of other organs (14) Patients with isolated liver resection (15) Loss of follow-up, such as only one visit; Patients with medical records or telephone follow-up for less than 1 year and no death outcome (16) Partial hepatectomy was performed on the donor of the parent liver transplantation (17) Palliative treatment for primary liver cancer patients

Design outcomes

Primary

MeasureTime frame
To evaluate the survival of primary HCC patients after hepatectomy at 1, 3, and 5 years;

Secondary

MeasureTime frame
The occurrence of surgical complications and long-term survival outcome were analyzed. The risk factors affecting prognosis were analyzed.;

Countries

China

Contacts

Public ContactLeida Zhang

The First Affiliated Hospital of PLA Army Medical University

2518569931@qq.com+86 135 0832 0249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026